Konan, Japan

Heihachiro Arai

This inventor holds 3 USPTO granted patents. Top assignee: Zeria Pharmaceutical Co., Ltd.. Active years: 1990-1995.


% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Konan, JP (1990 - 1993)
  • Saitama, JP (1995)

Company Filing History:


Years Active: 1990-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Heihachiro Arai: Innovator in Pharmaceutical Chemistry

Introduction

Heihachiro Arai is a notable inventor based in Konan, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on developing innovative drug compounds that have the potential to improve health outcomes.

Latest Patents

Arai's latest patents include several important advancements. One of his notable inventions is an "Arylalkanoylamine derivative and drug containing the same." Additionally, he has developed "Indoleacetic acid derivatives, process for their preparation." These patents reflect his commitment to advancing pharmaceutical science and improving therapeutic options.

Career Highlights

Heihachiro Arai is associated with Zeria Pharmaceutical Co., Ltd., where he has been instrumental in research and development. His expertise in drug formulation and synthesis has contributed to the company's reputation for innovation in the pharmaceutical industry.

Collaborations

Arai has collaborated with several talented individuals in his field, including Yoshiaki Tanaka and Naoki Nakata. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Heihachiro Arai's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development and therapeutic solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…